Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy

被引：7

作者：

Saliba, Antoine N. ^{[1
,2
]}

Xie, Zhuoer ^{[1
,2
]}

Higgins, Alexandra S. ^{[1
,2
]}

Andrade-Gonzalez, Xavier A. ^{[1
,2
]}

Fuentes-Bayne, Harry E. ^{[1
,2
]}

Hampel, Paul J. ^{[1
,2
]}

Kankeu Fonkoua, Lionel A. ^{[1
,2
]}

Childs, Daniel S. ^{[1
,2
]}

Rakshit, Sagar ^{[1
,2
]}

Bezerra, Evandro D. ^{[1
,2
]}

Kommalapati, Anuhya ^{[1
,2
]}

Lou, Yanyan ^{[3
]}

Rivera, Candido E. ^{[3
]}

Price, Katharine A. ^{[2
]}

Chintakuntlawar, Ashish ^{[2
]}

Yan, Yiyi ^{[2
]}

Schwecke, Anna J. ^{[2
]}

Block, Matthew S. ^{[2
]}

Thanarajasingam, Uma ^{[4
]}

Thanarajasingam, Gita ^{[1
]}

Wolanskyj-Spinner, Alexandra P. ^{[1
]}

Marshall, Ariela L. ^{[1
,5
]}

Kottschade, Lisa A. ^{[2
]}

Go, Ronald S. ^{[1
]}

Al-Kali, Aref ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol, 200 1 St SW, Rochester, MN USA

[2] Mayo Clin, Dept Oncol, Div Med Oncol, Rochester, MN USA

[3] Mayo Clin, Div Hematol & Oncol, Jacksonville, FL USA

[4] Mayo Clin, Div Rheumatol, Rochester, MN USA

[5] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 10期

关键词：

RITUXIMAB;

D O I：

10.1002/ajh.26273

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E362 / E367

页数：6

共 50 条

[1] Immune-Related Hematologic Adverse Events in the Context of Checkpoint Inhibitors
Saliba, Antoine
Xie, Zhuoer
Higgins, Ally
Andrade-Gonzalez, Xavier A.
Fuentes-Bayne, Harry E.
Hampel, Paul J.
Fonkoua, Lionel Kankeu
Childs, Daniel
Rakshit, Sagar
Bezerra, Evandro D.
Lou, Yanyan
Rivera, Candido E.
Price, Katharine
Yan, Yiyi
Schwecke, Anna
Block, Matthew S.
Thanarajasingam, Uma
Thanarajasingam, Gita
Wolanskyj, Alexandra P.
Marshall, Ariela L.
Kottschade, Lisa A.
Go, Ronald S.
Al-Kali, Aref
[J]. BLOOD, 2020, 136
[2] Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Therapy
Ho, Adrienne K.
Ho, Anthony M-H
Cooksley, Tim
Nguyen, Giang
Erb, Jason
Mizubuti, Glenio B.
[J]. ANESTHESIA AND ANALGESIA, 2021, 132 (02): : 374 - 383
[3] Pancreatic Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Therapy
Patel, Vanisha
Ashkar, Motaz
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S714 - S714
[4] Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy
Zhou, Nanruoyi
Velez, Maria A.
Owen, Dwight
Lisberg, Aaron E.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (09): : 1287 - 1290
[5] Renal immune-related adverse events of immune checkpoint inhibitor
Hu, Rongrong
Chen, Minjiang
Xu, Yan
Wang, Mengzhao
Zheng, Ke
Li, Xuemei
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (06) : 305 - 311
[6] Rheumatic Immune-Related Adverse Events-A Consequence of Immune Checkpoint Inhibitor Therapy
Bobirca, Anca
Bobirca, Florin
Ancuta, Ioan
Florescu, Alesandra
Padureanu, Vlad
Florescu, Dan Nicolae
Padureanu, Rodica
Florescu, Anca
Musetescu, Anca Emanuela
[J]. BIOLOGY-BASEL, 2021, 10 (06):
[7] Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy
Feldman, Theodore C.
Kaplan, David E.
Lin, Albert
La, Jennifer
Lee, Jerry S. H.
Aljehani, Mayada
Tuck, David P.
Brophy, Mary T.
Fillmore, Nathanael R.
Do, Nhan V.
[J]. JCO CLINICAL CANCER INFORMATICS, 2024, 8
[8] Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review
Khan, Shaheen
Gerber, David E.
[J]. SEMINARS IN CANCER BIOLOGY, 2020, 64 : 93 - 101
[9] Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy
Jing, Ying
Zhang, Yongchang
Wang, Jing
Li, Kunyan
Chen, Xue
Heng, Jianfu
Gao, Qian
Ye, Youqiong
Zhang, Zhao
Liu, Yaoming
Lou, Yanyan
Lin, Steven H.
Diao, Lixia
Liu, Hong
Chen, Xiang
Mills, Gordon B.
Han, Leng
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (10) : 1396 - 1404
[10] Life-Threatening Endocrinological Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy
Basek, Aleksandra
Jakubiak, Grzegorz K.
Cieslar, Grzegorz
Stanek, Agata
[J]. CANCERS, 2023, 15 (24)

← 1 2 3 4 5 →